Bill > SB273

This bill establishes a comprehensive regulatory framework for consumable hemp products in Alabama, with several key provisions. Starting January 1, 2026, consumable hemp products may only be sold in licensed pharmacies that obtain annual certification from the Alabama State Board of Pharmacy. These products must contain only nonpsychoactive cannabinoids derived from hemp cultivated within the state and must undergo rigorous testing for quality, potency, and safety. The Department of Agriculture and Industries will develop a seed-to-sale tracking system to monitor hemp cultivation and product processing, and will establish protocols for random product testing that check for cannabinoid content, heavy metals, chemical contamination, and other potential contaminants. Processors will be responsible for obtaining certificates of analysis before selling products, and testing laboratories must be internationally accredited. The bill also adds psychoactive derivatives of hemp to Schedule I controlled substances, effectively prohibiting their sale, and repeals existing legislation that prohibits selling psychoactive cannabinoids to minors. The new regulations aim to ensure consumer safety and create a controlled market for hemp-derived products, with all sales restricted to pharmacies and strict testing requirements in place.

Business and Industry

https://alison.legislature.state.al.us/bill-search